Mini-Symposia
How to Apply
___________________________________________________________________
Evans Center pre-Affinity Research Collaborative (ARC*) mini-symposium on:
Computational Genomic Models of Environmental & Chemical Carcinogenicity
Thursday, October 25, 2012 – 3:30p-6:00p
650 Albany Street – X714/15
PROGRAM
3:30-3:45 Introduction: Stefano Monti, Ph.D & David Sherr, Ph.D. – co-chairs
3:50-4:20 An Overview of DrugMatrix and its Application to Cancer Hazard Characterization
Scott Auerbach, Ph.D., National Toxicology Program / NIEHS
4:30-5:00 High-Throughput Transcriptomics – The Connectivity Map v2.0
Aravind Subramanian, Ph.D., Cancer Program, Broad Institute of MIT & Harvard
5:00-5:30 Open Discussion
5:30-6:00 Cheer/Cheese reception
For Inquiries, please contact Drs. Monti and/or Sherr ({smonti,dsherr}@bu.edu)
* http://www.bumc.bu.edu/evanscenteribr/
___________________________________________________________________
Evans Center Nanotheranostics ARC
Co-Sponsored by the Boston University Center for Nanoscience and Nanobiotechnology
NANOMEDICINE SYMPOSIUM: NANOTHERANOSTICS
Nanotechnology – Therapeutics – Diagnostics
NOV 20, 2012 1:30 – 6:30
PHOTONICS, 8 St. MARY’S ST, Room 906
PROGRAM:
1:30p Opening Remarks by Evans Center Director Katya Ravid, DSc/PhD, Professor of Medicine and Biochemistry
1:35p Nanodiagnostics for Cell Engineering Invited guest, Jeff W.M. Bulte, PhD, Professor of Biomedical Engineering, Chemical Engineering, and Radiology, Director, Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD
2:35p Multifunctional Nanoparticles for Medical Applications – from discovery to clinical trials Invited guest, Omid C. Farokhjad, MD, Associate Professor of Anesthesia, Harvard Medical School, Boston MA, Director, Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital, MA
3:35p Coffee Break
3:50p Nanotheranostics for Cardiovascular Disease and Cancer Invited guest, Gregory M. Lanza, MD, PhD, FACC, Washington University Consortium for Translational Research in Advancing Imaging and Nanomedicine, St. Louis, MO
4:50p Advancing NanoMedicine through NanoTheranostics – Opportunities, Challenges and Priorities Panel Discussion
Panelists: Greg M. Lanza; Jeff W. M. Bulte; Katya Ravid; Bennett Goldberg, PhD, Professor and Director of BU Center for Nanoscience and Nanobiotechnology; David Center, MD, Professor and Director of BU Clinical and Translational Science Institute; Alex Norbash, MD, FACR, Professor and Chair, Radiology; Jennifer E. Rosen, MD, FACS, Assistant Professor, Surgery
5:25p Closing Remarks by Dr. Bennett Goldberg
5:30p Reception
Send inquiries to: Robin E. MacDonald
Administrative Manager, Evans Center for Interdisciplinary Biomedical Research
E-mail: remac@bu.edu <remac@bu.edu>
___________________________________________________________________
ARC SYMPOSIUM ON OBESITY, INFLAMMATION AND CANCER
October 25, 2011, 1-5:30p
Thank you for making this event such a success!! Slides will be posted related to this symposium.
The Obesity, Cancer and Inflammation ARC, co-directed by Drs Gerald Denis and Barbara Nikolajczyk, hosted this exciting symposium focused on the cellular, molecular and epidemiological connections between obesity and cancer, some of which are likely based on inflammatory factors.
As part of an exciting afternoon of speakers, a greatly anticipated visit by Drs Christopher Still and Glenn Gerhard, from Geisinger Medical Center, emphasized their superbly well-characterized bariatric cohort and the metabolic improvements they observe after surgery. They joined in a lively debate on “Drugs vs Surgery for Obesity”, led by Dr Caroline Apovian, Director, Nutrition and Weight Management Center, BMC. Dr Deborah Bowen of the BU School of Public Health, and an expert in breast cancer, who discussed connections between socioeconomic variables and obesity. Dr Lynn Moore from BUSM Preventive Medicine discussed cancer rates and obesity in Framingham Study subjects. Dr Jennifer Snyder-Cappione, an immunologist formerly of UCSF discussed the roles of inflammatory cells in adipose tissue. Dr Valentina Perissi, a new member of the faculty in the Department of Biochemistry, delivered a presentation on novel pathways that link inflammation and insulin resistance in obesity. Dr Nikolajczyk presented new data on inflammatory cell cross talk in Type 2 diabetic patients. Dr Nikolajczyk also acted as a Discussant to summarize the day’s provocative themes and brought the event to a close.
This event was held at 650 Albany Street, EBRC conference room 714.
***********************************************
“New Frontiers in Molecular Medicine”
Mini-Symposium Honoring Dr. John ‘Jack’ Murphy
Friday, October 1, 2010
EBRC(X Bldg) 714&715, 650 Albany Street
***********************************************
***********************************************
Welcome and Greetings: Dr. Katya Ravid, Director, Evans Center
Plaque Presentation: Dr. David Coleman, Chairman, Department of Medicine
Introductory Remarks: Dr. Jack Murphy, Section Chief, Molecular Medicine
Dr. William Bishai, from Johns Hopkins School of Medicine: ”Intoxicated by Tuberculosis”
Dr. Fadi G. Lakkis, from Thomas E. Starzl Transplantation Institute, Pittsburgh, PA: ”The Innate Immune Response to Transplanted Organs”
Dr. Francine Foss, from Yale University: ”The Evolution of ONTAK: From Lymphoma to Immunotherapy”
Dr. John Mekalanos, from Harvard Medical School: “Bacteriophage and phage-like structures in the evolution of pathogenic Vibrio cholerae”
Dr. David Relman, from Stanford University: “The Human Body as Microbial Ecosystem”
Dr. Rino Rappuloi, from Novartis Vaccines and Diagnostics: ”CRM197 and the Beginning of Modern Vaccines”
Speakers joined Graduate Students and Post-Doctoral Fellows for a luncheon and lively discussion, and conversed with attendees during a special Oktoberfest reception to close our celebration.
“Controlling Hypertension: from basic research to the clinic”
April 16, 2010 (building X714-715)
Dr. Coleman presents a Recognition Plaque to Dr. H. Gavras 
Introduction by Dr. Haralambos Gavras
1. John Hall, PhD
Professor and Chairman
Department of Physiology
University of Mississippi Medical Center
Jackson, MS
Title: “Pathophysiology of hypertension in obesity/metabolic syndrome”
2. Genevieve Nguyen, M.D., Ph.D., FAHA
Senior Scientist
Collège de France
Paris, France
Title: “The (pro)renin receptor: biology and functions”
3. Hans Brunner, M.D.
Professor of Medicine
Division of Hypertension and Vascular Medicine
Centre Hospitalier, Universitaire Vaudois (CHUV)
Lausanne, SWITZERLAND
Title: “The development of renin inhibitors”
4. David Hyman, MD
Professor & Chief of General Internal Medicine
Baylor College of Medicine
Houston, TX
Title: “How come BP is not controlled yet? Inert MDs?
Inert patients? Inert systems? Inert drugs? Incorrect goals. ”
NANOMEDICINE SYMPOSIUM:co-organized by BU Nanotechnology Center, Evans Center and DOM (chaired by: Drs. Bennett Goldberg and Selim Unlu) Wednesday, May 13, 2009 Dr. Jeffery Schloss, co-chair of the NIH Nanotechnology Task Force “$1000 genomes — who needs them and how will we get them?”
Dr. Shuvo Roy, University of California, San Francisco -”Towards Total Renal Replacement using Silicon Nanopore Membrane Technology”
Dr. Daniel Kohane, Harvard Medical School and Children’s Hospital, Boston – “Drug delivery systems: nano, micro, and macro?”
IN PREPARATION for the symposium, faculty in nanoscience from Boston University presented research seminars in each of three areas (talks are now available online at http://nanoscience.bu.edu/nanomedicine/
Mini-symposium on Stem Cells and Regenerative Medicine (chaired by Dr. Katya Ravid), April 17, 2009
The Program:
1. “Development of induced pluripotent stem cells (iPS)”
Konrad Hochedlinger, Ph.D.
Associate Professor of Medicine
Harvard Medical School
Cancer Center and Center for Regenerative Medicine
2. “Stem cells of the skin: their biology and clinical promise”
Elaine Fuchs, Ph.D.
Rebecca C. Lancefield Professor
Investigator, Howard Hughes Medical Institute
Laboratory of Mammalian Cell Biology and Development
The Rockefeller University
3. “Endothelial progenitor cells in regenerative medicine “
Douglas W. Losordo, M.D.
Eileen M. Foell Professor of Heart Research
Director, Program in Cardiovascular Regenerative Medicine
Director, Feinberg Cardiovascular Research Institute
Northwestern University Feinberg School of Medicine
4. “Stem cell self-renewal versus cancer cell proliferation”
Sean J. Morrison, PhD
Henry Sewall Professor in Medicine
Director, Center for Stem Cell Biology
Howard Hughes Medical Institute Investigator
